MedImmune and Micromet AG, a wholly owned subsidiary of Micromet, Inc., will receive a milestone payment from MedImmune triggered by the IND filing. Micromet’s Proprietary BiTEĀ® Platform has Potential to Improve Treatment in Multiple Tumor Types. All-Cash Transaction Values Micromet at. The initial development plan contemplates EUR 25 million in funding of Micromet R&D activities if two BiTE antibodies are advanced to IND.

Author: Kezil Salkree
Country: Senegal
Language: English (Spanish)
Genre: Travel
Published (Last): 24 October 2012
Pages: 282
PDF File Size: 8.14 Mb
ePub File Size: 16.32 Mb
ISBN: 124-5-28302-305-3
Downloads: 31328
Price: Free* [*Free Regsitration Required]
Uploader: Meztirg

Delhi’s air quality turns ‘severe’: Micromet has established collaborations with MedImmune, Inc. Free Stock Analysis Report.

The Peaks and Valleys. Delhi records year’s second highest pollution level 23 Dec, The government today said that assistive devices for the physically-challenged will be charged at a concessional 5 per cent.

All News Videos Photos. Micromet could also earn up to double-digit royalties on worldwide net sales. ET EnergyWorld A one stop platform that caters to the pulse of the pulsating energy. Prior to that, Mr. Have you read these stories? Schnittker received his B. Micromet will leverage its BiTE technology, and Amgen will have the right to pursue development and commercialization of compounds for up to two of these targets. This is the second highest pollution level of this year.

In the presence of BiTE antibodies, T cells have been demonstrated to serially eliminate tumor cells, which explains the activity of BiTE antibodies at very low concentrations.


Micromet and Amgen entered a deal under which Micromet will work to discover antibodies against three undisclosed tumor targets from Amgen. TERI 17 Apr, Micromet is responsible for the development and commercialization of the candidate inEurope. The candidate is being developed to treat patients suffering from advanced gastrointestinal cancers.

Micromet: Latest News & Videos, Photos about Micromet | The Economic Times

Air pollutant concentrations “violated standards” at most places in Delhi on the second day of the odd-even scheme whose second phase has been rolled out in the national capital, TERI said. Government 4 Jul, Amgen will lead the clinical development, manufacturing, and commercialization of any products resulting from the collaboration. By continuing to use our site, you are agreeing to the use of mifromet as set in our privacy policy.

Zacks offers multiple investment products and services to help investors achieve superior returns. Two Phase 2 clinical trials for the treatment of patients with breast cancer and prostate cancer have been completed in Q3,with adecatumumab MTa recombinant human monoclonal antibody. New York, Aug 30 IANS In a finding that could make the process of removing salt from seawater easier, faster and cheaper than ever before, researchers have discovered that carbon nanotubes of a certain size act as the perfect filter for salt — the most abundant water contaminant.

Zacks Investment Research is one of the most highly regarded micromt in the investment industry.

Good News for Micromet

US offices to be located in the Washington, DC area. Top 10 Molecular Millionaires of MT is an antibody generated with the proprietary bispecific T-cell engager BiTE antibody platform. You won’t be able to use WhatsApp on these devices in Top 25 Biotech Companies of Now, The next challenge is to get the instalments to come through the bank accounts of the customers.


Banks have become the largest provider of micro-credit with a loan outstanding of Rs 38, crore and 36 per cent share.

Good News for Micromet

Bio-weapon experts aren’t buying the Tesla Model X’s bio-weapon defense mode 1 Oct, Prior to joining Genaera, Mr. Commercializing Continuous Processing in Pharma. In addition to the finance, business development and legal functions, Micromet is planning to expand the US headquarters by adding a development team for US clinical trials and regulatory interactions with the FDA.

MT is being developed in collaboration with Serono.

The move from the current Carlsbad headquarters in California to the East Coast will be completed during the 4 th quarter. Schnittker has extensive micromft in the financial management of publicly listed and privately held biotechnology and pharmaceutical companies.

Under the terms of the deal, MedImmune is responsible for the development and commercialization of the candidate in the US and outside Europe. Top 10 Pharma Companies of